Despite the acknowledged influence of cognition on patients' capacity to consent to treatment, the specific neuropsychological domains involved remain elusive, as does the role of executive functions. We investigated possible associations between executive functions and decisional capacity in a sample of acute psychiatric inpatients. Patients were recruited and evaluated through the MacArthur Competence Assessment Tool for Treatment (MacCAT-T), the 24-item Brief Psychiatric Rating Scale (BPRS), the Mini-Mental State Examination (MMSE), and the Wisconsin Card Sorting Test (WCST). Patients with poor executive functioning performed worse in MacCAT understanding, appreciation, and expression of a choice, compared with good performers. These findings point to the importance of cognition in decisional capacity processes. In addition, the strong association found between learning abilities and informed consent decision-making provide empirical evidence indicating possible cognitive enhancement strategies that may improve psychiatric patients' competency.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: American Psychiatric Association.
2.
AppelbaumP. S. & RothL. H. (1982). Competency to consent to research: A psychiatric overview. Archives of General Psychiatry, 39(8), 951–958.
3.
AppelbaumP. S. & GrissoT. (2001). MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR). Sarasota: Professional Resource Press.
4.
AppelbaumP. S. (2006). Decisional capacity of patients with schizophrenia to consent to research: Taking stock. Schizophrenia Bulletin, 32(1), 22–25.
5.
BarchD. M. & CeaserA. (2012). Cognition in schizophrenia: Core psychological and neural mechanisms. Trends in Cognitive Sciences, 16(1), 27–34.
6.
BersaniG.ClementeR.GherardelliS., & PancheriP. (2004). Deficit of executive functions in schizophrenia: Relationship to neurological soft signs and psychopathology. Psychopathology, 37(3), 118–123.
7.
CairnsR.MaddockC.BuchananA.DavidA. S.HaywardP.RichardsonG.SzmuklerG., & HotopfM. (2005). Reliability of mental capacity assessments in psychiatric inpatients. British Journal of Psychiatry, 187, 372–378.
8.
CarpenterW. T.GoldJ. M.LahtiA. C.QueernC. A.ConleyR. R.BartkoJ. J.KovnickJ., & AppelbaumP. S. (2000). Decisional capacity for informed consent in schizophrenia research. Archives of General Psychiatry, 57(6), 533–538.
9.
DunnL. B. (2006). Capacity to consent to research in schizophrenia: The expanding evidence base. Behavioral Sciences and the Law, 24(4), 431–445.
10.
DunnL. B.PalmerB. W.AppelbaumP. S.SaksE. R.AaronsG. A., & JesteD. V. (2007). Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: Differences among three standards for the MacCAT-CR in patients with schizophrenia. Schizophrenia Research, 89(1–3), 110–118.
11.
FolsteinM.FolsteinS., & McHughP. (1975). Mini-mental state: A practical method for grading the cognitive state of the patient for the clinician. Journal of Psychiatric Research, 12, 189–198.
12.
GoldsteinG. (1990). Neuropsychological heterogeneity in schizophrenia: A consideration of abstraction and problem-solving abilities. Archives of Clinical Neuropsychology, 5(3), 251–264.
13.
GrissoT. & AppelbaumP. S. (1995). The MacArthur Treatment Competence Study, III: Abilities of patients to consent to psychiatric and medical treatments. Law and Human Behavior, 19(2), 149–174.
14.
GrissoT. & AppelbaumP. S. (1998). Assessing competence to consent to treatment: A guide for physicians and other health professionals. New York: Oxford University Press.
15.
GrissoT.AppelbaumP. S., & Hill-FotouhiC. (1997). The MacCAT-T: A clinical tool to assess patients' capacities to make treatment decisions. Psychiatric Services, 48(11), 1415–1419.
16.
HeatonR. K. (1981). The Wisconsin Card Sorting Test Manual. Odessa, FL: Psychological Assessment Resources.
17.
HellvinT.SundetK.SimonsenC.AminoffS. R.LagerbergT. V.AndreassenO. A., & MelleI. (2012). Neurocognitive functioning in patients recently diagnosed with bipolar disorder. Bipolar Disorder, 14(3), 227–238.
18.
HolzerJ. C.GanslerD. A.MoczynskiN. P., & FolsteinM. F. (1997). Cognitive functions in the informed consent evaluation process: A pilot study. Journal of the American Academy of Psychiatry and the Law, 25(4), 531–540.
19.
HoweV.FoisterK.JenkinsK.SkeneL.CopolovD., & KeksN. (2005). Competence to give informed consent in acute psychosis is associated with symptoms rather than diagnosis. Schizophrenia Research, 77(2–3), 211–214.
20.
JanofskyJ. S.McCarthyR. J., & FolsteinM. F. (1992). The Hopkins Competency Assessment Test: A brief method for evaluating patient's capacity to give informed consent. Hospital and Community Psychiatry, 43(2), 132–136.
21.
JesteD. V.DeppC. A., & PalmerB. W. (2006). Magnitude of impairment in decisional capacity in people with schizophrenia compared to normal subjects: An overview. Schizophrenia Bulletin, 32(1), 121–128.
22.
JesteD. V.PalmerB. W.AppelbaumP. S.GolshanS.GloriosoD.. (2007). A new brief instrument for assessing decisional capacity for clinical research. Archives of General Psychiatry, 64(8), 966–974.
23.
KarlawishJ. H.CasarettD. J.JamesB. D.XieS. X., & KimS. Y. (2005). The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment. Neurology, 64(9), 1514–1519.
24.
KorenD.SeidmanL. J.HarrisonR. H.LyonsM. J.KremenW. S.. (1998). Factor structure of the Wisconsin Card Sorting Test: Dimensions of deficit in schizophrenia. Neuropsychology, 12(2), 289–302.
25.
KorenD.PoyurovskyM.SeidmanL. J.GoldsmithM.WengerS., & KleinE. M. (2005). The neuropsychological basis of competence to consent in first-episode schizophrenia: A pilot metacognitive study. Biological Psychiatry, 57(6), 609–616.
26.
KovnickJ. A.AppelbaumP. S.HogeS. K., & LeadbetterR. A. (2003). Competence to consent to research among long-stay inpatients with chronic schizophrenia. Psychiatric Services, 54(9), 1247–1252.
27.
KurtzM. M. & WexlerB. E. (2006). Differences in performance and learning proficiency on the Wisconsin Card Sorting Test in schizophrenia: Do they reflect distinct neurocognitive subtypes with distinct functional profiles?Schizophrenia Research, 81(2–3), 167–171.
28.
LehS. E.PetridesM., & StrafellaA. P. (2010). The neural circuitry of executive functions in healthy subjects and Parkinson's disease. Neuropsychopharmacology, 35(1), 70–85.
29.
MarsonD. C.IngramK. K.CodyH. A., & HarrelL. E. (1995). Assessing the competency of patients with Alzheimer's disease under different legal standards: A prototype instrument. Archives of Neurology, 52(10), 949–954.
30.
Mesholam-GatelyR. I.GiulianoA. J.GoffK. P.FaraoneS. V., & SeidmanL. J. (2009). Neurocognition in first-episode schziphrenia: A meta-analytic review. Neuropsychology, 23(3), 315–336.
31.
MoserD. J.SchultzS. K.ArndtS.BenjaminM. L.FlemingF. W.BremsC. S.. (2002). Capacity to provide informed consent for participation in schizophrenia and HIV research. American Journal of Psychiatry, 159(7), 1201–1207.
32.
OwenG. S.RichardsonG.DavidA. S.SzmuklerG.HaywardP., & HotopfM. (2008). Mental capacity to make decisions on treatment in people admitted to psychiatric hospitals: Cross-sectional study. British Medical Journal, 337(7660), 40–42.
33.
PalmerB. W. (2006). Informed consent for schizophrenia research: What is an investigator (or IRB) to do?Behavioral Sciences and the Law, 24(4), 447–452.
34.
PalmerB. W.DunnL. B.AppelbaumP. S., & JesteD. V. (2004). Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. Archives of General Psychiatry, 61(3), 230–236.
35.
PalmerB. W.DunnL. B.DeppC. A.EylerL. T., & JesteD. V. (2007). Decisional capacity to consent to research among patients with bipolar disorder: Comparison with schizophrenia patients and healthy subjects. Journal of Clinical Psychiatry, 68, 689–696.
36.
PalmerB. W. & JesteD. V. (2006). Relationship of individual cognitive abilities to specific components of decisional capacity among middle-aged and older patients with schizophrenia. Schizophrenia Bulletin, 32(1), 98–106.
37.
PalmerB. W. & SavlaG. N. (2007). The association of specific neuropsychological deficits with capacity to consent to research or treatment. Journal of the International Neuropsychological Society, 13(6), 1047–1059.
38.
RaymontV.BingleyW.BuchananA.DavidA. S.HaywardP.WesselyS., & HotopfM. (2004). Prevalence of mental incapacity in medical in-patients and associated risk factors: Cross-sectional study. Lancet, 364(9443), 1421–1427.
39.
RoyallD. R.MahurinR. K., & GrayK. F. (1992). Bedside assessment of executive cognitive impairment: The Executive Interview. Journal of the American Geriatrics Society, 40(12), 1221–1226.
40.
RuggeriM.KoeterM.ScheneA.BonettoC.Vàzquez-BarqueroJ. L.BeckerT.. (2005). Factor solution of the BPRS-expanded version in schizophrenic outpatients living in five European countries. Schizophrenia Research, 75(1), 107–117.
41.
RüschN.SpoletiniI.WilkeM.BriaP.Di PaolaM.Di IulioF. (2007). Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia. Schizophrenia Research, 93, 79–89.
42.
SchillerstromJ. E.RickenbackerD.JoshiK. G., & RoyallD. R. (2007). Executive function and capacity to consent to a noninvasive research protocol. American Journal of Geriatric Psychiatry, 15(2), 159–162.
43.
StrattaP.ArduiniL.DaneluzzoE.RinaldiO.Di GenovaA., & RossiA. (2004). Relationship of good and poor Wisconsin Card Sorting Test performance to illness duration in schizophrenia: A cross-sectional analysis. Psychiatry Research, 121(3), 219–227.
44.
TorrentC.Martinez-AránA.CdelBonnin M.ReinaresM.DabanC.SoléB.. (2012). Long-term outcome of cognitive impairment in bipolar disorder. Journal of Clinical Psychiatry, 73(7), e899–905.
45.
VenturaJ.LukoffD.NuechterleinK. H.LibermanR. P.GreenM., & ShanerA. (1993). Appendix 1: Brief Psychiatric Rating Scale (BPRS) Expanded Version (4.0) scales, anchor points and administration manual. International Journal of Methods in Psychiatric Research, 3, 227–243.
